British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine
FEBRUARY 3, 2020 8:06:17 AM
GSK will make its "adjuvant platform technology" available for developing a vaccine against the 2019-nCoV virus, according to the statement.
.png)
No hay comentarios:
Publicar un comentario